Telix Pharmaceuticals Lim... (TLX)

NASDAQ: TLX · Real-Time Price · USD

17.41

-0.16 (-0.91%)

At close: Apr 29, 2025, 3:53 PM

17.52

0.66%

After-hours: Apr 29, 2025, 07:09 PM EDT

Telix Pharmaceuticals Balance Sheet Statement

Financials in AUD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	710.35M	123.24M	116.33M	22.04M	77.94M	759.6K	1.03M	970.9K	840.89K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	6.09M	12.26M	n/a	n/a	n/a	78.09K	78.07K	n/a	151.25K
Other Long-Term Assets	74.58M	586K	327K	212K	183K	3.98M	2.59M	-5.19M	2.87M
Receivables	158.99M	64.78M	39.35M	19.42M	12.4M	3.38M	3.22M	4.58M	4.33M
Inventory	38.14M	17.31M	8.48M	3.45M	633K	3.1M	3.12M	2.81M	2.63M
Other Current Assets	n/a	7.1M	6.57M	1.43M	1.79M	1.15M	591.93K	2M	931.08K
Total Current Assets	918.56M	224.85M	173.23M	47.54M	93.63M	8.38M	7.97M	10.36M	8.73M
Property-Plant & Equipment	54.32M	30.49M	18.84M	6.33M	4.82M	3.24M	3.09M	2.97M	3.18M
Goodwill & Intangibles	416.13M	109.66M	58.98M	55.73M	59.19M	1.06M	1.06M	967K	1.03M
Total Long-Term Assets	597.87M	173.45M	82.12M	62.27M	64.19M	9.01M	8.31M	-1.25M	9.89M
Total Assets	1.52B	398.3M	255.35M	109.81M	157.82M	17.4M	16.28M	9.11M	18.61M
Account Payables	68.7M	32.84M	16.81M	11.88M	5.81M	1.34M	5.29M	3.61M	2.07M
Deferred Revenue	11.25M	n/a	63.17M	19.32M	7.09M	174.64K	1.42M	n/a	1.27M
Short-Term Debt	18.99M	964K	641K	632K	767K	403.23K	3.67M	n/a	4.14M
Other Current Liabilities	109.67M	74.14M	4.94M	6.14M	6.29M	10.82M	9.6M	14.23M	6.78M
Total Current Liabilities	330.91M	157.41M	85.56M	37.98M	19.96M	12.74M	19.98M	17.84M	14.26M
Long-Term Debt	551.82M	8.21M	9.8M	1.91M	1.44M	1.27M	2.05M	5.24M	79.09K
Other Long-Term Liabilities	44.67M	76.1M	79.98M	67.77M	57.41M	1.38M	-3.06M	n/a	-1.36M
Total Long-Term Liabilities	617.31M	91.98M	89.79M	69.67M	58.85M	7.14M	7.32M	5.24M	6.12M
Total Liabilities	948.22M	249.39M	175.35M	107.66M	78.81M	19.87M	27.3M	6.72M	20.38M
Total Debt	581.45M	17.45M	10.45M	2.54M	2.21M	1.67M	5.72M	6.39M	4.22M
Common Stock	n/a	446.27M	370.97M	170.84M	167.06M	18.46K	5.68K	2.6K	2.78K
Retained Earnings	-212.96M	-263.67M	-272.81M	-173.47M	-92.96M	-47.09M	-44.97M	n/a	-33.08M
Comprehensive Income	184.4M	-33.69M	-18.15M	4.79M	4.92M	-9.4M	-9.08M	-7.2M	-7.78M
Shareholders Equity	568.21M	148.91M	80.01M	2.16M	79.02M	-2.48M	-11.02M	-5.08M	-1.77M
Total Investments	6.09M	12.26M	n/a	n/a	n/a	78.09K	78.07K	n/a	151.25K